Recent Quarter Total Invested
$30.63 M
Recent Quarter Institutional Ownership Percentage
39.74%
Total Invested of Last Quarter
$47.35 M
Ownership Percentage of Last Quarter
62.8%
IO Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 08/14/2024 | 6.17 M | $7.22 M | 0.00% | 9.37% |
| NOVO HOLDINGS A/S | 08/20/2024 | 4.43 M | $5.18 M | -12.95% | 6.72% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 3.64 M | $4.26 M | 0.00% | 5.53% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 2.34 M | $2.74 M | 0.00% | 3.55% |
| MARSHALL WACE, LLP | 08/14/2024 | 2.11 M | $2.46 M | 0.00% | 3.20% |
| MORGAN STANLEY | 08/14/2024 | 1.97 M | $2.31 M | -10.24% | 2.99% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.65 M | $1.93 M | -10.45% | 2.51% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.55 M | $1.81 M | -10.38% | 2.35% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 987,654 | $1.16 M | 0.00% | 1.50% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 864,197 | $1.01 M | 0.00% | 1.31% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 493,827 | $577,778 | 0.00% | 0.75% |
| FMR LLC | 08/13/2024 | 314,600 | $368,082 | 0.00% | 0.48% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 192,670 | $225,424 | 100.00% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 180,800 | $211,536 | 8.13% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 124,623 | $145,809 | 0.00% | 0.19% |
| CITADEL ADVISORS LLC | 08/14/2024 | 86,894 | $101,666 | 48.23% | 0.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 33,307 | $38,969 | 0.00% | 0.05% |
| XTX TOPCO LTD | 08/12/2024 | 26,555 | $31,069 | 67.36% | 0.04% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 08/09/2024 | 4,166 | $4,874 | 100.00% | 0.01% |
| UBS GROUP AG | 08/14/2024 | 3,280 | $3,838 | 100.00% | 0.01% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/21/2024 | 0 | $0 | -100.00% | 0.00% |
IO Biotech, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IOBT shares?
During the previous two years, 20 institutional investors and hedge funds held shares of IO Biotech, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 6.17 M
Novo Holdings A/S: 4.43 M
Samsara BioCapital, LLC: 3.64 M
PFM Health Sciences, LP: 2.34 M
MARSHALL WACE, LLP: 2.11 M
MORGAN STANLEY: 1.97 M
-
What percentage of IO Biotech, Inc. stock is owned by institutional investors?
39.74% of IO Biotech, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IOBT ?
Institutional investors have bought a total of 26.18 M shares in the last 24 months. This purchase volume represents approximately $27.23 M in transactions.